Least cardiovascular side effects found in –
**Core Concept**
Metformin is a commonly used oral antidiabetic drug that belongs to the biguanide class. Its primary mechanism of action involves the inhibition of hepatic gluconeogenesis, which is the process by which the liver produces glucose. This action is mediated through the activation of AMP-activated protein kinase (AMPK), leading to the suppression of key enzymes involved in gluconeogenesis.
**Why the Correct Answer is Right**
Metformin has been shown to have a favorable cardiovascular profile compared to other antidiabetic medications. This is attributed to its ability to improve insulin sensitivity, reduce blood pressure, and decrease triglyceride levels. Additionally, metformin has been found to have a neutral effect on body weight and does not cause fluid retention, which are common side effects of other antidiabetic medications.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because thiazolidinediones, such as pioglitazone, have been associated with increased cardiovascular risk due to their effects on fluid retention and increased risk of heart failure.
**Option B:** This option is incorrect because sulfonylureas, such as glipizide, can cause hypoglycemia and weight gain, which can increase cardiovascular risk.
**Option C:** This option is incorrect because meglitinides, such as repaglinide, can cause hypoglycemia and weight gain, which can increase cardiovascular risk.
**Option D:** This option is incorrect because DPP-4 inhibitors, such as sitagliptin, have been associated with an increased risk of pancreatitis and cardiovascular events.
**Clinical Pearl / High-Yield Fact**
It's essential to note that all antidiabetic medications carry some degree of cardiovascular risk, and the choice of medication should be individualized based on the patient's specific needs and risk factors.
**Correct Answer: A. Metformin**